We are live on ! Find out more
KRSA icon

Korsana Biosciences

17 hedge funds and large institutions have $1.06M invested in Korsana Biosciences in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 17 → 17 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

2.48% less ownership

Funds ownership: 13.78% → 11.3% (-2.5%)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

79% less capital inflows, than outflows

Capital inflows: $8.51K | Capital outflows: $40.1K

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
1
Increased
2
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

KRSA Hedge Fund Activity: Q2 2025 in Review

17 of the 7,630 institutional investors tracked by Wall St. Rank reported a position in Korsana Biosciences (KRSA) for Q2 2025, worth a combined $1.06M — up 13% from $932K a quarter earlier.

Fund positioning in KRSA was balanced in Q2 2025: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 4 trimmed.

The largest buyer was Tower Research Capital (TRC), adding an estimated $5.1K. The largest seller was Tyndall Capital Partners, cutting an estimated $28.6K.

  • 17 institutional investors held Korsana Biosciences (KRSA) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $1.06M of Korsana Biosciences stock for Q2 2025, up 13% quarter-over-quarter.
  • 1 fund opened new Korsana Biosciences positions in Q2 2025 and 1 closed out, a net change of 0 holders.
  • The largest Korsana Biosciences buyer in Q2 2025 was Tower Research Capital (TRC), an estimated $5.1K added.
  • The largest Korsana Biosciences seller in Q2 2025 was Tyndall Capital Partners, an estimated $28.6K sold.

Based on aggregated 13F filings for Q2 2025.